Pyxis Oncology to Present at the Jefferies London Healthcare Conference

Rhea-AI Summary

Pyxis Oncology, Inc. (Nasdaq: PYXS) announced its participation in the virtual Jefferies London Healthcare Conference on November 18-19, 2021. The management will present and conduct one-on-one investor meetings. The presentation will be available on-demand starting November 18, and a replay will be accessible on Pyxis Oncology's website after the conference concludes. The company focuses on developing innovative cancer therapeutics, including antibody drug conjugates and monoclonal antibodies, to improve patient outcomes.

CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), today announced that management will present at and host one-on-one investor meetings during the virtual portion of the Jefferies London Healthcare Conference, taking place November 18-19, 2021. The presentation will be available on-demand for attendees during the virtual conference beginning on November 18, 2021. A replay of the presentation will be available on the Events and Presentation page on Pyxis Oncology’s website following the conference’s conclusion.

Webcast: https://wsw.com/webcast/jeff201/pyxs/1894104

About Pyxis
Pyxis Oncology, Inc. is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. Pyxis develops its product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Since its launch in 2019, Pyxis has developed a broad portfolio of novel antibody drug conjugate, or ADC, product candidates, and monoclonal antibody, or mAb, preclinical discovery programs that it is developing as monotherapies and in combination with other therapies.

Investor Relations Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com

Media Contact
Jason Braco, Ph.D.
LifeSci Communications
jbraco@lifescicomms.com

FAQ

What is the date of the Jefferies London Healthcare Conference for Pyxis Oncology?

The Jefferies London Healthcare Conference for Pyxis Oncology will take place on November 18-19, 2021.

Where can I access the Pyxis Oncology presentation from the conference?

The presentation will be available on-demand starting November 18, 2021, and a replay can be found on Pyxis Oncology's Events and Presentation page following the conference.

What is the focus of Pyxis Oncology's development efforts?

Pyxis Oncology is focused on developing next-generation therapeutics to target difficult-to-treat cancers, including antibody drug conjugates and monoclonal antibodies.

What is the stock symbol for Pyxis Oncology?

The stock symbol for Pyxis Oncology is PYXS.

Who can I contact for investor relations at Pyxis Oncology?

For investor relations inquiries, you can contact Ashley R. Robinson at LifeSci Advisors.